LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $796,000 | -88.9% | 8,000 | -86.7% | 0.03% | -98.0% |
| Q2 2016 | $7,156,000 | -0.3% | 60,000 | -10.4% | 1.32% | +9.5% |
| Q1 2016 | $7,175,000 | -1.2% | 67,000 | 0.0% | 1.21% | +14.8% |
| Q4 2015 | $7,264,000 | +26.6% | 67,000 | 0.0% | 1.05% | +36.6% |
| Q3 2015 | $5,739,000 | +191.5% | 67,000 | +81.1% | 0.77% | +233.3% |
| Q4 2014 | $1,969,000 | +186.2% | 37,000 | +152.6% | 0.23% | +159.6% |
| Q3 2014 | $688,000 | – | 14,647 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |